Legal experts say recent court cases and a new guideline from the US Patent and Trademark Office on patent-eligible subject matter have created a lot of ambiguity for companies. The current situation is especially vexing for digital health companies that may want to patent processes and software rather than traditional hardware.
As the medtech industry continues to grapple with the nuances of what is and isn’t patentable, Medtech Insight spoke with...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?